公司概覽
業務類別 Drug Manufacturers - General
業務概覽 AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.
公司地址 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
電話號碼 +1 847 932-7900
傳真號碼 --
公司網頁 https://www.abbvie.com
員工數量 57000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD Executive Vice President and Chief Operations Officer 美元 1.05M 20/02/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 美元 1.70M 23/03/2026
Mr. Jeffrey Ryan Stewart Executive Vice President and Chief Commercial Officer 美元 1.32M 20/02/2026
Dr. Nicholas J. Donoghoe, M.D. Executive Vice President, Chief Business and Strategy Officer -- 20/02/2026
Mr. Scott T. Reents Executive Vice President and Chief Financial Officer 美元 1.12M 20/02/2026
Mr. Perry C. Siatis Executive Vice President, General Counsel and Secretary -- 20/02/2026
Dr. Roopal Thakkar, M.D. Executive Vice President, Research and Development and Chief Scientific Officer 美元 1.15M 20/02/2026
Mr. David R. Purdue Principal Accounting Officer, Senior Vice President and Controller -- 20/02/2026
Mr. Demetris D. Crum Executive Vice President and Chief Human Resources Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Frederick H. Waddell Independent Director 23/03/2026
Ms. Rebecca B. Roberts Independent Director 23/03/2026
Mr. Thomas C. Freyman Independent Director 23/03/2026
Mr. Thomas J. Falk Independent Director 23/03/2026
Mr. Edward J. Rapp Independent Director 23/03/2026
Ms. Roxanne S. Austin Lead Independent Director 23/03/2026
Mr. Brett J. Hart Independent Director 23/03/2026
Mr. William H.L. Burnside Independent Director 23/03/2026
Ms. Melody B. Meyer Independent Director 23/03/2026
Mr. Robert A. Michael Chairman of the Board and Chief Executive Officer 23/03/2026
Dr. John M. Carethers Independent Director 15/10/2026
Dr. Susan E. Quaggin, M.D. Independent Director 23/03/2026
 
所屬ETF (更新日期: 14/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
HEQJH Diversified Income Fund0.0002%30/09/2026
RSMVRelative Strength Managed Vol Stgy ETF0.0002%30/10/2026
IQSZInvesco Global Equity Net Zero ETF0.0002%30/10/2026
STXVStrive 1000 Value ETF0.0002%30/10/2026
NDOWAnydrus Advantage ETF0.0002%30/10/2026
DIVYSound Equity Dividend Income ETF0.0002%30/10/2026
CSHPiShares Dynamic Short-Term Active ETF0.0002%30/10/2026
DXUVDimensional US Vector Equity ETF0.0002%24/09/2026
EQALInvesco Russell 1000 Equal Weight ETF0.0002%30/10/2026
STXGStrive 1000 Growth ETF0.0002%30/10/2026
JDOCJPMorgan Healthcare Leaders ETF0.0002%30/10/2026
AVUQAvantis U.S. Quality ETF0.0002%30/10/2026
CDXSimplify High Yield ETF0.0002%30/10/2026
DEXDelaware Enhanced Gbl Div & Income0.0002%31/01/2023
SECAMain Active Rotation ETF0.0001%30/10/2026
JDIVJPMorgan US Dividend ETF0.0001%31/08/2022
MEDIHarbor Health Care ETF0.0001%31/10/2026
PQUSPictet AI Enhanced US Equity ETF0.0001%30/10/2026
HDUSHartford Disciplined US Equity ETF0.0001%31/10/2026
SPXNProShares S&P 500® ex-Financials0.0001%30/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20   21    22    23    24    25    26    27    28    29    30    31    32  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.